Objective: Cardiovascular disease (CVD) remains the leading cause of mortality in systemic lupus erythematosus (SLE). This study compared the performance […]
Objective: To develop a score for a diagnosis of cytopenias from systemic lupus erythematosus (SLE) activity and determine the usefulness
Background: Reproductive health is a critical issue for women with autoimmune rheumatic diseases (ARDs), yet significant gaps in knowledge and
Background: Psoriatic arthritis (PsA) is a complex immune-mediated heterogeneous inflammatory disease. Treatment decisions are challenging given the multisystem involvement. To
Objective: This study seeks to assess the temporal patterns of osteoarthritis (OA) in Mexico from 1990 to 2021 using the
Objective: Biological drugs have revolutionized the treatment of rheumatic diseases, but their high cost has contributed to increased prescription drug
Although antinuclear antibody (ANA) positivity on HEp-2 cells is a mandatory criterion for the classification of systemic lupus erythematosus (SLE),
Background: Options for systemic sclerosis–associated interstitial lung disease (SSc-ILD) have evolved rapidly. Mycophenolate mofetil (MMF) has replaced cyclophosphamide (CYC) in
Objective: To describe Raynaud phenomenon (RP) management practices for systemic sclerosis (SSc) patients among US community-based rheumatologists. Methods: We identified
Objective: To evaluate the HALP (hemoglobin-albumin-lymphocyte-platelet) score at lupus nephritis (LN) diagnosis in predicting renal relapse (RR). Methods: Nested case-control
Purpose: To assess whether sex and comorbidity are associated with the risk of 90-day readmission and associated mortality after nonelective
Organized by the Department of Rheumatology at AIIMS Delhi and the Center for Rheumatic Diseases (CRD), Pune, the event brought
… Rheumatology, AIIMS, Delhi, and the Centre for Rheumatic Diseases (CRD), Pune. “Arthritis is a leading non-communicable disease. It erodes
Br J Dermatol. 2025 Sep 29:ljaf383. doi: 10.1093/bjd/ljaf383. Online ahead of print. NO ABSTRACT PMID:41021706 | DOI:10.1093/bjd/ljaf383
JMIR Infodemiology. 2025 Sep 29;5:e65319. doi: 10.2196/65319. ABSTRACT BACKGROUND: Cannabis is the third most consumed drug worldwide, with its use
J Gerontol A Biol Sci Med Sci. 2025 Sep 29:glaf210. doi: 10.1093/gerona/glaf210. Online ahead of print. ABSTRACT BACKGROUND: To address
The event, jointly organised by the Department of Rheumatology, AIIMS Delhi, and the Center for Rheumatic Diseases (CRD), Pune, brought
QD Clinic: Stick or twist (when not to change treatment) Dr. Richard Conway, Dublin, discusses a case about when not
Polypharmacy Impairs Rheumatoid Arthritis Outcomes A French early rheumatoid arthritis (RA) study has shown that polyp https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 09/29/2025
Front. Med. Sec. Rheumatology. Volume 12 – 2025 | doi: 10.3389/fmed.2025.1694721 …
This article originally appeared on Rheumatology Advisor. References: Sigmo GD, Hauge S, Hetland HB, et al. Men with psoriatic arthritis …
U.S. inpatient data show patients with autoimmune rheumatic diseases face higher risks of infection, respiratory failure, and amputation after …
Malignancies Not Increased with Biologic Therapies The risk of malignancy in RA patients receiving biologic agents was https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
Yan Zhang,1 Zelin He,1 Zikang Yin,1 Ji Wang,2 Wanyi Gao,1 Ligang Jie1 1Department of Rheumatology and Clinical Immunology, Zhujiang Hospital, …
The research sheds light on how DIORA1 operates within cellular processes and may provide new insights into its connection to
… called DIORA1 (FAM167A), previously linked to autoimmune rheumatic diseases such as …
